% alzhub.org library filter % Source: https://alzhub.org/research?author=Atri+A&score_min=67 % 4 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{cummings2026-c800c391, author = {Cummings, J. L. and Atri, A. and Scheltens, P. and others}, title = {{Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (EVOKE and EVOKE+): two phase 3, randomised, placebo-controlled trials}}, journal = {The Lancet}, year = {2026}, doi = {10.1016/s0140-6736(26)00459-9}, pmid = {41865758}, url = {https://doi.org/10.1016/s0140-6736(26)00459-9} } @article{cummings2025-39780249, author = {Cummings, J. L. and Atri, A. and Feldman, H. H. and Hansson, O. and Sano, M. and Knop, F. K. and Johannsen, P. and León, T. and others}, title = {{evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2025}, doi = {10.1186/s13195-024-01666-7}, pmid = {39780249}, url = {https://doi.org/10.1186/s13195-024-01666-7} } @article{atri2018-29318278, author = {Atri, A. and Frölich, L. and Ballard, C. and Tariot, P. N. and Molinuevo, J. L. and Boneva, N. and Windfeld, K. and Raket, L. L. and others}, title = {{Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials}}, journal = {JAMA}, year = {2018}, doi = {10.1001/jama.2017.20373}, pmid = {29318278}, url = {https://doi.org/10.1001/jama.2017.20373} } @article{atri2024-39713942, author = {Atri, A. and Dickerson, B. C. and Clevenger, C. and Karlawish, J. and Knopman, D. and Lin, P. J. and Norman, M. and Onyike, C. and Sano, M. and Scanland, S. and others}, title = {{Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care}}, journal = {Alzheimer's \& Dementia}, year = {2024}, doi = {10.1002/alz.14333}, pmid = {39713942}, url = {https://doi.org/10.1002/alz.14333} }